Skip to main content
. Author manuscript; available in PMC: 2012 Feb 15.
Published in final edited form as: Clin Cancer Res. 2011 Jun 24;17(16):5490–5500. doi: 10.1158/1078-0432.CCR-11-0724

Figure 2.

Figure 2

Kaplan-Meier plots for rs1649942 genotype effect on progression free survival (PFS) and overall survival (OS) probabilities in all phase 1 AOCS patients (n=377) and a subset of optimally debulked patients (n=271). Log rank p-values compare survival probabilities across genotypes, and tick marks indicate censoring events. A) rs1649942 genotype effect on PFS in all patients and B) optimally debulked patients; C) OS in all patients, and D) optimally debulked patients.